Richard Resnick, writing at the sequence data management firm Genome Quest's blog, discusses his expectations of the "implications of exponential growth of global whole genome sequencing capacity." Resnick expects that by 2011, "catalogues of human variation will become large-scale for the first time," and that "early-stage sequence-based diagnostics will find their way into the leading-edge labs and hospitals." By 2012, he expects somewhere aroun